Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Cirrhosis Collaborators.

Lancet Gastroenterol Hepatol. 2020 Jan 22. pii: S2468-1253(19)30349-8. doi: 10.1016/S2468-1253(19)30349-8. [Epub ahead of print]

PMID:
31981519
2.

Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Congenital Heart Disease Collaborators.

Lancet Child Adolesc Health. 2020 Jan 21. pii: S2352-4642(19)30402-X. doi: 10.1016/S2352-4642(19)30402-X. [Epub ahead of print]

PMID:
31978374
3.

Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors.

Cortesi PA, Castaman G, Trifirò G, Creazzola SS, Improta G, Mazzaglia G, Molinari AC, Mantovani LG.

Thromb Haemost. 2019 Dec 30. doi: 10.1055/s-0039-3401822. [Epub ahead of print]

PMID:
31887777
4.

Critical Assessment of Streptomyces spp. Able to Control Toxigenic Fusaria in Cereals: A Literature and Patent Review.

Colombo EM, Kunova A, Cortesi P, Saracchi M, Pasquali M.

Int J Mol Sci. 2019 Dec 4;20(24). pii: E6119. doi: 10.3390/ijms20246119. Review.

5.

Italy's health performance, 1990-2017: findings from the Global Burden of Disease Study 2017.

GBD 2017 Italy Collaborators.

Lancet Public Health. 2019 Dec;4(12):e645-e657. doi: 10.1016/S2468-2667(19)30189-6. Epub 2019 Nov 20.

6.

Selection of an Endophytic Streptomyces sp. Strain DEF09 From Wheat Roots as a Biocontrol Agent Against Fusarium graminearum.

Colombo EM, Kunova A, Pizzatti C, Saracchi M, Cortesi P, Pasquali M.

Front Microbiol. 2019 Oct 11;10:2356. doi: 10.3389/fmicb.2019.02356. eCollection 2019.

7.

Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology.

Strazzabosco M, Cortesi PA, Conti S, Okolicsanyi S, Rota M, Ciaccio A, Cozzolino P, Fornari C, Gemma M, Scalone L, Cesana G, Fabris L, Colledan M, Fagiuoli S, Ideo G, Zavaglia C, Perricone G, Munari LM, Mantovani LG, Belli LS.

Liver Int. 2020 Jan;40(1):60-73. doi: 10.1111/liv.14285. Epub 2019 Nov 12.

PMID:
31654608
8.

Dual-active antifungal agents containing strobilurin and SDHI-based pharmacophores.

Zuccolo M, Kunova A, Musso L, Forlani F, Pinto A, Vistoli G, Gervasoni S, Cortesi P, Dallavalle S.

Sci Rep. 2019 Aug 6;9(1):11377. doi: 10.1038/s41598-019-47752-x.

9.

Evaluation of in-vitro methods to select effective streptomycetes against toxigenic fusaria.

Colombo EM, Pizzatti C, Kunova A, Gardana C, Saracchi M, Cortesi P, Pasquali M.

PeerJ. 2019 May 22;7:e6905. doi: 10.7717/peerj.6905. eCollection 2019.

10.

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Neurology Collaborators.

Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.

11.

Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.

Cortesi PA, Barca R, Giudicatti G, Mossini S, Ciaccio A, Iannazzo S, Micale M, Cesana G, Mantovani LG.

Aliment Pharmacol Ther. 2019 May;49(9):1126-1133. doi: 10.1111/apt.15201. Epub 2019 Mar 6. Review.

PMID:
30843268
12.

Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Population and Fertility Collaborators.

Lancet. 2018 Nov 10;392(10159):1995-2051. doi: 10.1016/S0140-6736(18)32278-5. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

14.
16.

Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Mortality Collaborators.

Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

18.

Patients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases.

Scalone L, Sarzi-Puttini P, Sinigaglia L, Montecucco C, Giacomelli R, Lapadula G, Olivieri I, Giardino AM, Cortesi PA, Mantovani LG, Mecchia M.

Patient Prefer Adherence. 2018 Oct 16;12:2153-2168. doi: 10.2147/PPA.S168458. eCollection 2018.

19.

Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.

Belli LS, Perricone G, Adam R, Cortesi PA, Strazzabosco M, Facchetti R, Karam V, Salizzoni M, Andujar RL, Fondevila C, De Simone P, Morelli C, Fabregat-Prous J, Samuel D, Agarwaal K, Moreno Gonzales E, Charco R, Zieniewicz K, De Carlis L, Duvoux C; all the contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA).

J Hepatol. 2018 Oct;69(4):810-817. doi: 10.1016/j.jhep.2018.06.010. Epub 2018 Jun 27.

PMID:
29940268
20.

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.

GBD 2016 Healthcare Access and Quality Collaborators.

Lancet. 2018 Jun 2;391(10136):2236-2271. doi: 10.1016/S0140-6736(18)30994-2. Epub 2018 Jun 1.

Supplemental Content

Loading ...
Support Center